COVID-19 Vaccine Acceptance among Health Care Workers in the United States

被引:402
作者
Shekhar, Rahul [1 ]
Sheikh, Abu Baker [1 ]
Upadhyay, Shubhra [1 ]
Singh, Mriganka [2 ]
Kottewar, Saket [3 ]
Mir, Hamza [4 ]
Barrett, Eileen [1 ]
Pal, Suman [1 ]
机构
[1] Univ New Mexico, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87106 USA
[2] Case Western Reserve Univ, Univ Hosp, Dept Med, Cleveland, OH 44139 USA
[3] Univ Texas Hlth San Antonio, Div Hosp Med, Dept Med, San Antonio, TX 78229 USA
[4] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87106 USA
关键词
Covid-19; vaccine; healthcare workers; United States; INFLUENZA VACCINATION; SEASONAL INFLUENZA; IMMUNIZATION; REFUSAL; ATTITUDES;
D O I
10.3390/vaccines9020119
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Acceptance of the COVID-19 vaccine will play a major role in combating the pandemic. Healthcare workers (HCWs) are among the first group to receive vaccination, so it is important to consider their attitudes about COVID-19 vaccination to better address barriers to widespread vaccination acceptance. Methods: We conducted a cross sectional study to assess the attitude of HCWs toward COVID-19 vaccination. Data were collected between 7 October and 9 November 2020. We received 4080 responses out of which 3479 were complete responses and were included in the final analysis. Results: 36% of respondents were willing to take the vaccine as soon as it became available while 56% were not sure or would wait to review more data. Only 8% of HCWs do not plan to get vaccine. Vaccine acceptance increased with increasing age, education, and income level. A smaller percentage of female (31%), Black (19%), Lantinx (30%), and rural (26%) HCWs were willing to take the vaccine as soon as it became available than the overall study population. Direct medical care providers had higher vaccine acceptance (49%). Safety (69%), effectiveness (69%), and speed of development/approval (74%) were noted as the most common concerns regarding COVID-19 vaccination in our survey.
引用
收藏
页码:1 / 18
页数:15
相关论文
共 30 条
[1]  
[Anonymous], 2020, Global map
[2]  
[Anonymous], A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older ClinicalTrials.gov Identifier: NCT04505722
[3]  
[Anonymous], NCT NUMBER NCT043862
[4]  
[Anonymous], NCT04405076
[5]  
[Anonymous], ClinicalTrials.gov Identifier
[6]   Influenza Vaccine and Healthcare Workers [J].
del Carmen Aguilar-Diaz, Fatima ;
Eugenia Jimenez-Corona, Maria ;
Ponce-de-Leon-Rosales, Samuel .
ARCHIVES OF MEDICAL RESEARCH, 2011, 42 (08) :652-657
[7]   Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic [J].
Detoc, Maelle ;
Bruel, Sebastien ;
Frappe, Paul ;
Tardy, Bernard ;
Botelho-Nevers, Elisabeth ;
Gagneux-Brunon, Amandine .
VACCINE, 2020, 38 (45) :7002-7006
[8]   The WHO Tailoring Immunization Programmes (TIP) approach: Review of implementation to date [J].
Dube, Eve ;
Leask, Julie ;
Wolff, Brent ;
Hickler, Benjamin ;
Balaban, Victor ;
Hosein, Everold ;
Habersaat, Katrine .
VACCINE, 2018, 36 (11) :1509-1515
[9]   Attitudes Toward a Potential SARS-CoV-2 Vaccine A Survey of US Adults [J].
Fisher, Kimberly A. ;
Bloomstone, Sarah J. ;
Walder, Jeremy ;
Crawford, Sybil ;
Fouayzi, Hassan ;
Mazor, Kathleen M. .
ANNALS OF INTERNAL MEDICINE, 2020, 173 (12) :964-+
[10]   COVID-19 herd immunity: where are we? [J].
Fontanet, Arnaud ;
Cauchemez, Simon .
NATURE REVIEWS IMMUNOLOGY, 2020, 20 (10) :583-584